MEXT Japan Survey: Cervical Cancer Vaccine Side Effects Interfered With School Life In 171 Cases
This article was originally published in PharmAsia News
One hundred and seventy-one female junior and senior high school students in Japan experienced some sort of trouble during school life that was caused by the cervical cancer vaccine last year, according to a survey released Sept. 9 by the Ministry of Education.
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.